Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence (Q57628870)
Jump to navigation
Jump to search
article by Marcello Disertori et al published January 2006 in Journal of Cardiovascular Medicine
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence |
article by Marcello Disertori et al published January 2006 in Journal of Cardiovascular Medicine |
Statements
Rationale and design of the GISSI-Atrial Fibrillation trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence (English)
0 references
January 2006
0 references
7
0 references
29-38
0 references
1
0 references